APO Research
Talk to an analyst

APO RESEARCH · REPORT

AML Screening

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AML Screening Market Outlook and Growth Opportunities 2026

5 March 2026209 pages

Choose your research edition.

Industry ResearchAML Screening Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal AML Screening Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal AML Screening Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AML Screening Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal AML Screening Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global AML Screening market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AML Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AML Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AML Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AML Screening market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AML Screening market include Shufti Pro, ComplyAdvantage, KYC Hub, Sumsub, Sterling RISQ, Sanction Scanner, Jumio, LexisNexis Risk Solutions and Fiserv, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AML Screening market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AML Screening and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AML Screening revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AML Screening market.

AML Screening Segment by Company

Shufti Pro

ComplyAdvantage

KYC Hub

Sumsub

Sterling RISQ

Sanction Scanner

Jumio

LexisNexis Risk Solutions

Fiserv

NICE Actimize

Verafin Inc.

Truth Technologies

iDenfy

Kroll

YOUVERIFY

BAE Systems

AML Screening Segment by Type

Sanctions Screening

Watch List Screening

Politically Exposed Person (PEP) Screening

Bad Media Screening

AML Screening Segment by Application

Government

Enterprise

Others

AML Screening Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AML Screening status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AML Screening key companies, revenue, market share, and recent developments.

3. To split the AML Screening breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AML Screening market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AML Screening significant trends, drivers, influence factors in global and regions.

6. To analyze AML Screening competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AML Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AML Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AML Screening.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AML Screening industry.

Chapter 3: Detailed analysis of AML Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AML Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AML Screening in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AML Screening Industry Trends Table 2. AML Screening Industry Drivers Table 3. AML Screening Industry Opportunities and Challenges Table 4. AML Screening Industry Restraints Table 5. Global AML Screening Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AML Screening Revenue Share by Company (2021-2026) Table 7. Global AML Screening Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AML Screening Key Company Manufacturing Base & Headquarters Table 9. Global AML Screening Company, Product Type & Application Table 10. Global AML Screening Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AML Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Sanctions Screening Table 15. Significant Companies of Watch List Screening Table 16. Significant Companies of Politically Exposed Person (PEP) Screening Table 17. Significant Companies of Bad Media Screening Table 18. Global AML Screening Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global AML Screening Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global AML Screening Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global AML Screening Sales Value Share by Type (2021-2026) Table 22. Global AML Screening Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Government Table 24. Significant Companies of Enterprise Table 25. Significant Companies of Others Table 26. Global AML Screening Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AML Screening Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global AML Screening Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global AML Screening Sales Value Share by Application (2021-2026) Table 30. Global AML Screening Sales Value Share by Application (2027-2032) Table 31. Global AML Screening Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AML Screening Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global AML Screening Sales Value Share by Region (2021-2026) Table 34. Global AML Screening Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global AML Screening Sales Value Share by Region (2027-2032) Table 36. Global AML Screening Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global AML Screening Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global AML Screening Sales Value Market Share by Country (2021-2026) Table 39. Global AML Screening Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global AML Screening Sales Value Market Share by Country (2027-2032) Table 41. Shufti Pro Company Information Table 42. Shufti Pro Business Overview Table 43. Shufti Pro AML Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Shufti Pro AML Screening Product Portfolio Table 45. Shufti Pro Recent Development Table 46. ComplyAdvantage Company Information Table 47. ComplyAdvantage Business Overview Table 48. ComplyAdvantage AML Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. ComplyAdvantage AML Screening Product Portfolio Table 50. ComplyAdvantage Recent Development Table 51. KYC Hub Company Information Table 52. KYC Hub Business Overview Table 53. KYC Hub AML Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. KYC Hub AML Screening Product Portfolio Table 55. KYC Hub Recent Development Table 56. Sumsub Company Information Table 57. Sumsub Business Overview Table 58. Sumsub AML Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Sumsub AML Screening Product Portfolio Table 60. Sumsub Recent Development Table 61. Sterling RISQ Company Information Table 62. Sterling RISQ Business Overview Table 63. Sterling RISQ AML Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Sterling RISQ AML Screening Product Portfolio Table 65. Sterling RISQ Recent Development Table 66. Sanction Scanner Company Information Table 67. Sanction Scanner Business Overview Table 68. Sanction Scanner AML Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Sanction Scanner AML Screening Product Portfolio Table 70. Sanction Scanner Recent Development Table 71. Jumio Company Information Table 72. Jumio Business Overview Table 73. Jumio AML Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Jumio AML Screening Product Portfolio Table 75. Jumio Recent Development Table 76. LexisNexis Risk Solutions Company Information Table 77. LexisNexis Risk Solutions Business Overview Table 78. LexisNexis Risk Solutions AML Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. LexisNexis Risk Solutions AML Screening Product Portfolio Table 80. LexisNexis Risk Solutions Recent Development Table 81. Fiserv Company Information Table 82. Fiserv Business Overview Table 83. Fiserv AML Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Fiserv AML Screening Product Portfolio Table 85. Fiserv Recent Development Table 86. NICE Actimize Company Information Table 87. NICE Actimize Business Overview Table 88. NICE Actimize AML Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. NICE Actimize AML Screening Product Portfolio Table 90. NICE Actimize Recent Development Table 91. Verafin Inc. Company Information Table 92. Verafin Inc. Business Overview Table 93. Verafin Inc. AML Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Verafin Inc. AML Screening Product Portfolio Table 95. Verafin Inc. Recent Development Table 96. Truth Technologies Company Information Table 97. Truth Technologies Business Overview Table 98. Truth Technologies AML Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Truth Technologies AML Screening Product Portfolio Table 100. Truth Technologies Recent Development Table 101. iDenfy Company Information Table 102. iDenfy Business Overview Table 103. iDenfy AML Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. iDenfy AML Screening Product Portfolio Table 105. iDenfy Recent Development Table 106. Kroll Company Information Table 107. Kroll Business Overview Table 108. Kroll AML Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Kroll AML Screening Product Portfolio Table 110. Kroll Recent Development Table 111. YOUVERIFY Company Information Table 112. YOUVERIFY Business Overview Table 113. YOUVERIFY AML Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. YOUVERIFY AML Screening Product Portfolio Table 115. YOUVERIFY Recent Development Table 116. BAE Systems Company Information Table 117. BAE Systems Business Overview Table 118. BAE Systems AML Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. BAE Systems AML Screening Product Portfolio Table 120. BAE Systems Recent Development Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. AML Screening Product Image Figure 2. Global AML Screening Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AML Screening Market Size (2021-2032) & (US$ Million) Figure 4. Global AML Screening Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Sanctions Screening Image Figure 8. Watch List Screening Image Figure 9. Politically Exposed Person (PEP) Screening Image Figure 10. Bad Media Screening Image Figure 11. Global AML Screening Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global AML Screening Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global AML Screening Sales Value Share by Type (2021-2032) Figure 14. Government Image Figure 15. Enterprise Image Figure 16. Others Image Figure 17. Global AML Screening Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AML Screening Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global AML Screening Sales Value Share by Application (2021-2032) Figure 20. Global AML Screening Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global AML Screening Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America AML Screening Sales Value (2021-2032) & (US$ Million) Figure 23. North America AML Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe AML Screening Sales Value (2021-2032) & (US$ Million) Figure 25. Europe AML Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific AML Screening Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific AML Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America AML Screening Sales Value (2021-2032) & (US$ Million) Figure 29. South America AML Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa AML Screening Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa AML Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt AML Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt AML Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt AML Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Sanctions Screening
  • Watch List Screening
  • Politically Exposed Person (PEP) Screening
  • Bad Media Screening
Applications
  • Government
  • Enterprise
  • Others
Companies covered
  • Shufti Pro
  • ComplyAdvantage
  • KYC Hub
  • Sumsub
  • Sterling RISQ
  • Sanction Scanner
  • Jumio
  • LexisNexis Risk Solutions
  • Fiserv
  • NICE Actimize
  • Verafin Inc.
  • Truth Technologies
  • iDenfy
  • Kroll
  • YOUVERIFY
  • BAE Systems

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AML Screening Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AML Screening Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AML Screening Market Dynamics
  1. 2.1 AML Screening Industry Trends
  2. 2.2 AML Screening Industry Drivers
  3. 2.3 AML Screening Industry Opportunities and Challenges
  4. 2.4 AML Screening Industry Restraints
3 AML Screening Market by Company
  1. 3.1 Global AML Screening Company Revenue Ranking in 2025
  2. 3.2 Global AML Screening Revenue by Company (2021-2026)
  3. 3.3 Global AML Screening Company Ranking (2024-2026)
  4. 3.4 Global AML Screening Company Manufacturing Base and Headquarters
  5. 3.5 Global AML Screening Company Product Type and Application
  6. 3.6 Global AML Screening Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AML Screening Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AML Screening Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AML Screening Market by Type
  1. 4.1 AML Screening Type Introduction
  2. 4.1.1 Sanctions Screening
  3. 4.1.2 Watch List Screening
  4. 4.1.3 Politically Exposed Person (PEP) Screening
  5. 4.1.4 Bad Media Screening
  6. 4.2 Global AML Screening Sales Value by Type
  7. 4.2.1 Global AML Screening Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global AML Screening Sales Value by Type (2021-2032)
  9. 4.2.3 Global AML Screening Sales Value Share by Type (2021-2032)
5 AML Screening Market by Application
  1. 5.1 AML Screening Application Introduction
  2. 5.1.1 Government
  3. 5.1.2 Enterprise
  4. 5.1.3 Others
  5. 5.2 Global AML Screening Sales Value by Application
  6. 5.2.1 Global AML Screening Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global AML Screening Sales Value by Application (2021-2032)
  8. 5.2.3 Global AML Screening Sales Value Share by Application (2021-2032)
6 AML Screening Regional Value Analysis
  1. 6.1 Global AML Screening Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AML Screening Sales Value by Region (2021-2032)
  3. 6.2.1 Global AML Screening Sales Value by Region: 2021-2026
  4. 6.2.2 Global AML Screening Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AML Screening Sales Value (2021-2032)
  7. 6.3.2 North America AML Screening Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AML Screening Sales Value (2021-2032)
  10. 6.4.2 Europe AML Screening Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AML Screening Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AML Screening Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AML Screening Sales Value (2021-2032)
  16. 6.6.2 South America AML Screening Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AML Screening Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AML Screening Sales Value Share by Country, 2025 VS 2032
7 AML Screening Country-level Value Analysis
  1. 7.1 Global AML Screening Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AML Screening Sales Value by Country (2021-2032)
  3. 7.2.1 Global AML Screening Sales Value by Country (2021-2026)
  4. 7.2.2 Global AML Screening Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AML Screening Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AML Screening Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AML Screening Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AML Screening Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AML Screening Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AML Screening Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AML Screening Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AML Screening Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AML Screening Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AML Screening Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AML Screening Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AML Screening Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AML Screening Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AML Screening Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AML Screening Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AML Screening Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AML Screening Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AML Screening Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AML Screening Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AML Screening Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AML Screening Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AML Screening Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AML Screening Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AML Screening Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AML Screening Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AML Screening Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AML Screening Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AML Screening Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AML Screening Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AML Screening Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AML Screening Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AML Screening Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AML Screening Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AML Screening Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AML Screening Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AML Screening Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AML Screening Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AML Screening Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AML Screening Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AML Screening Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AML Screening Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AML Screening Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AML Screening Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AML Screening Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AML Screening Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AML Screening Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AML Screening Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AML Screening Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AML Screening Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AML Screening Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AML Screening Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AML Screening Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AML Screening Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AML Screening Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AML Screening Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AML Screening Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AML Screening Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AML Screening Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AML Screening Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AML Screening Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AML Screening Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AML Screening Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AML Screening Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AML Screening Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AML Screening Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AML Screening Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AML Screening Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AML Screening Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AML Screening Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AML Screening Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AML Screening Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AML Screening Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AML Screening Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AML Screening Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AML Screening Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AML Screening Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AML Screening Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AML Screening Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AML Screening Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AML Screening Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AML Screening Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AML Screening Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AML Screening Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AML Screening Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shufti Pro
  2. 8.1.1 Shufti Pro Company Information
  3. 8.1.2 Shufti Pro Business Overview
  4. 8.1.3 Shufti Pro AML Screening Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shufti Pro AML Screening Product Portfolio
  6. 8.1.5 Shufti Pro Recent Developments
  7. 8.2 ComplyAdvantage
  8. 8.2.1 ComplyAdvantage Company Information
  9. 8.2.2 ComplyAdvantage Business Overview
  10. 8.2.3 ComplyAdvantage AML Screening Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ComplyAdvantage AML Screening Product Portfolio
  12. 8.2.5 ComplyAdvantage Recent Developments
  13. 8.3 KYC Hub
  14. 8.3.1 KYC Hub Company Information
  15. 8.3.2 KYC Hub Business Overview
  16. 8.3.3 KYC Hub AML Screening Revenue and Gross Margin (2021-2026)
  17. 8.3.4 KYC Hub AML Screening Product Portfolio
  18. 8.3.5 KYC Hub Recent Developments
  19. 8.4 Sumsub
  20. 8.4.1 Sumsub Company Information
  21. 8.4.2 Sumsub Business Overview
  22. 8.4.3 Sumsub AML Screening Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sumsub AML Screening Product Portfolio
  24. 8.4.5 Sumsub Recent Developments
  25. 8.5 Sterling RISQ
  26. 8.5.1 Sterling RISQ Company Information
  27. 8.5.2 Sterling RISQ Business Overview
  28. 8.5.3 Sterling RISQ AML Screening Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sterling RISQ AML Screening Product Portfolio
  30. 8.5.5 Sterling RISQ Recent Developments
  31. 8.6 Sanction Scanner
  32. 8.6.1 Sanction Scanner Company Information
  33. 8.6.2 Sanction Scanner Business Overview
  34. 8.6.3 Sanction Scanner AML Screening Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanction Scanner AML Screening Product Portfolio
  36. 8.6.5 Sanction Scanner Recent Developments
  37. 8.7 Jumio
  38. 8.7.1 Jumio Company Information
  39. 8.7.2 Jumio Business Overview
  40. 8.7.3 Jumio AML Screening Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jumio AML Screening Product Portfolio
  42. 8.7.5 Jumio Recent Developments
  43. 8.8 LexisNexis Risk Solutions
  44. 8.8.1 LexisNexis Risk Solutions Company Information
  45. 8.8.2 LexisNexis Risk Solutions Business Overview
  46. 8.8.3 LexisNexis Risk Solutions AML Screening Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LexisNexis Risk Solutions AML Screening Product Portfolio
  48. 8.8.5 LexisNexis Risk Solutions Recent Developments
  49. 8.9 Fiserv
  50. 8.9.1 Fiserv Company Information
  51. 8.9.2 Fiserv Business Overview
  52. 8.9.3 Fiserv AML Screening Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Fiserv AML Screening Product Portfolio
  54. 8.9.5 Fiserv Recent Developments
  55. 8.10 NICE Actimize
  56. 8.10.1 NICE Actimize Company Information
  57. 8.10.2 NICE Actimize Business Overview
  58. 8.10.3 NICE Actimize AML Screening Revenue and Gross Margin (2021-2026)
  59. 8.10.4 NICE Actimize AML Screening Product Portfolio
  60. 8.10.5 NICE Actimize Recent Developments
  61. 8.11 Verafin Inc.
  62. 8.11.1 Verafin Inc. Company Information
  63. 8.11.2 Verafin Inc. Business Overview
  64. 8.11.3 Verafin Inc. AML Screening Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Verafin Inc. AML Screening Product Portfolio
  66. 8.11.5 Verafin Inc. Recent Developments
  67. 8.12 Truth Technologies
  68. 8.12.1 Truth Technologies Company Information
  69. 8.12.2 Truth Technologies Business Overview
  70. 8.12.3 Truth Technologies AML Screening Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Truth Technologies AML Screening Product Portfolio
  72. 8.12.5 Truth Technologies Recent Developments
  73. 8.13 iDenfy
  74. 8.13.1 iDenfy Company Information
  75. 8.13.2 iDenfy Business Overview
  76. 8.13.3 iDenfy AML Screening Revenue and Gross Margin (2021-2026)
  77. 8.13.4 iDenfy AML Screening Product Portfolio
  78. 8.13.5 iDenfy Recent Developments
  79. 8.14 Kroll
  80. 8.14.1 Kroll Company Information
  81. 8.14.2 Kroll Business Overview
  82. 8.14.3 Kroll AML Screening Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Kroll AML Screening Product Portfolio
  84. 8.14.5 Kroll Recent Developments
  85. 8.15 YOUVERIFY
  86. 8.15.1 YOUVERIFY Company Information
  87. 8.15.2 YOUVERIFY Business Overview
  88. 8.15.3 YOUVERIFY AML Screening Revenue and Gross Margin (2021-2026)
  89. 8.15.4 YOUVERIFY AML Screening Product Portfolio
  90. 8.15.5 YOUVERIFY Recent Developments
  91. 8.16 BAE Systems
  92. 8.16.1 BAE Systems Company Information
  93. 8.16.2 BAE Systems Business Overview
  94. 8.16.3 BAE Systems AML Screening Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BAE Systems AML Screening Product Portfolio
  96. 8.16.5 BAE Systems Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst